Wealth Enhancement Advisory Services
DARE icon

Wealth Enhancement Advisory Services’s Dare Bioscience DARE Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,573
Closed -$10.4K – 2824
2024
Q2 		$10.4K Hold
2,573
– – ﹤0.01% 2514
2024
Q1 		$15.1K Hold
2,573
– – ﹤0.01% 2392
2023
Q4 		$9.54K Buy
+2,573
New +$11.8K ﹤0.01% 2286

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wealth Enhancement Advisory Services's DARE Position: Q3 2024 in Review

Wealth Enhancement Advisory Services sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 2,573 shares — an estimated $10.4K sold.

Wealth Enhancement Advisory Services first reported a position in DARE in Q4 2023 and held it in 3 quarters. The position peaked at $15.1K in Q1 2024. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

  • Wealth Enhancement Advisory Services reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 2,573 Dare Bioscience shares in Q3 2024, an estimated $10.4K.
  • Wealth Enhancement Advisory Services first reported a position in Dare Bioscience in Q4 2023 and held it in 3 quarters.
  • Wealth Enhancement Advisory Services's Dare Bioscience position peaked at $15.1K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2024, filed 24 Oct 2024.